UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mechanisms of the androgen receptor splicing in prostate cancer cells

Oncogene, 2014-06, Vol.33 (24), p.3140-3150

2014

Volltextzugriff (PDF)

Role of OATP transporters in steroid uptake by prostate cancer cells in vivo

Prostate cancer and prostatic diseases, 2017-03, Vol.20 (1), p.20-27

2017

Volltextzugriff (PDF)

A Phase 2 Trial of External Beam Radiation Therapy (RT) and Abiraterone (ABI) in Men With Localized Prostate Cancer (PCa): A Safety and Pharmacodynamics Assessment

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S406-S407

2014

Volltextzugriff (PDF)

Abiraterone, Androgen Deprivation Therapy, and Radiotherapy for Localized Intermediate/High Risk Prostate Cancer: Long-Term Follow-Up of the RAD1 Phase 2 Trial

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e228-e229

2022

Volltextzugriff (PDF)

Abiraterone in the treatment of metastatic castration-resistant prostate cancer

Cancer management and research, 2014-01, Vol.6 (default), p.39-51

Mostaghel, Elahe A

2014

Volltextzugriff (PDF)

A phase II trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer

Cancer, 2018-11, Vol.125 (4), p.524-532

2018

Volltextzugriff (PDF)

DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223

Clinical genitourinary cancer, 2018-04, Vol.16 (2), p.106-110

2018

Volltextzugriff (PDF)

Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells

American journal of physiology. Lung cellular and molecular physiology, 2001-12, Vol.281 (6), p.1453-L1463

2001

Volltextzugriff (PDF)

Tumor response and adaptation to CYP17 inhibition in prostate cancer: Induction of steroidogenesis and androgen receptor splice variants

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.18-18

2011

Volltextzugriff (PDF)

Effect of tissue ischemia on prostatic androgen levels

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4643-4643

2010

Volltextzugriff (PDF)

Effects of 5α reductase inhibition on stromal and epithelial genes associated with the development of high grade prostate cancer

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.5054-5054

2008

Volltextzugriff (PDF)

Pulmonary Surfactant Proteins A and D Directly Suppress CD3+/CD4+ Cell Function: Evidence for Two Shared Mechanisms

The Journal of immunology (1950), 2002-11, Vol.169 (10), p.5844-5850

2002

Volltextzugriff (PDF)

Coreceptor-Independent T Cell Activation in Mice Expressing MHC Class II Molecules Mutated in the CD4 Binding Domain

The Journal of immunology (1950), 1998-12, Vol.161 (12), p.6559-6566

1998

Volltextzugriff (PDF)

Disruption of the CD4-Major Histocompatibility Complex Class II Interaction Blocks the Development of CD4+T Cells in vivo

Proceedings of the National Academy of Sciences - PNAS, 1998-04, Vol.95 (8), p.4493-4498

1998

Volltextzugriff (PDF)

Pulmonary Surfactant Proteins A and D Directly Suppress CD3 super(+)/CD4 super(+) Cell Function: Evidence for Two Shared Mechanisms

The Journal of immunology (1950), 2002-11, Vol.169 (10), p.5844-5850

2002

Volltextzugriff (PDF)

Disruption of the CD4-major histocompatibility complex class II interaction blocks the development of CD4 super(+) T cells in vivo

Proceedings of the National Academy of Sciences - PNAS, 1998-04, Vol.95 (8), p.4493-4498

1998

Volltextzugriff (PDF)

Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer

Clinical cancer research, 2019-01, Vol.25 (1), p.426-439

2019

Volltextzugriff (PDF)

Neoadjuvant Enzalutamide Prior to Prostatectomy

Clinical cancer research, 2017-05, Vol.23 (9), p.2169-2176

2017

Volltextzugriff (PDF)

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression : Therapeutic implications for castration-resistant prostate cancer

Cancer research (Chicago, Ill.), 2007-05, Vol.67 (10), p.5033-5041

2007

Volltextzugriff (PDF)

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

The Journal of clinical investigation, 2021-06, Vol.131 (12)

2021

Volltextzugriff (PDF)

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

The Journal of clinical investigation, 2021-05, Vol.131 (10), p.1-15

2021

Volltextzugriff (PDF)

Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial

Trials, 2021-07, Vol.22 (1), p.431-431, Article 431

2021

Volltextzugriff (PDF)

Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer

Endocrinology (Philadelphia), 2020-02, Vol.161 (2), p.1

2020

Volltextzugriff (PDF)

Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition

European urology, 2017-10, Vol.72 (4), p.499-506

2017

Volltextzugriff (PDF)

Integrative Clinical Genomics of Advanced Prostate Cancer

Cell, 2015-07, Vol.162 (2), p.454-454

2015

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mechanisms of the androgen receptor splicing in prostate cancer cells

Role of OATP transporters in steroid uptake by prostate cancer cells in vivo

A Phase 2 Trial of External Beam Radiation Therapy (RT) and Abiraterone (ABI) in Men With Localized Prostate Cancer (PCa): A Safety and Pharmacodynamics Assessment

Abiraterone, Androgen Deprivation Therapy, and Radiotherapy for Localized Intermediate/High Risk Prostate Cancer: Long-Term Follow-Up of the RAD1 Phase 2 Trial

Abiraterone in the treatment of metastatic castration-resistant prostate cancer

A phase II trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer

DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223

Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells

Tumor response and adaptation to CYP17 inhibition in prostate cancer: Induction of steroidogenesis and androgen receptor splice variants

Effect of tissue ischemia on prostatic androgen levels

Effects of 5α reductase inhibition on stromal and epithelial genes associated with the development of high grade prostate cancer

Pulmonary Surfactant Proteins A and D Directly Suppress CD3+/CD4+ Cell Function: Evidence for Two Shared Mechanisms

Coreceptor-Independent T Cell Activation in Mice Expressing MHC Class II Molecules Mutated in the CD4 Binding Domain

Disruption of the CD4-Major Histocompatibility Complex Class II Interaction Blocks the Development of CD4+T Cells in vivo

Pulmonary Surfactant Proteins A and D Directly Suppress CD3 super(+)/CD4 super(+) Cell Function: Evidence for Two Shared Mechanisms

Disruption of the CD4-major histocompatibility complex class II interaction blocks the development of CD4 super(+) T cells in vivo

Contribution of Adrenal Glands to Intratumor Androgens and Growth of Castration-Resistant Prostate Cancer

Neoadjuvant Enzalutamide Prior to Prostatectomy

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression : Therapeutic implications for castration-resistant prostate cancer

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth

Hormonal intervention for the treatment of veterans with COVID-19 requiring hospitalization (HITCH): a multicenter, phase 2 randomized controlled trial of best supportive care vs best supportive care plus degarelix: study protocol for a randomized controlled trial

Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer

Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition

Integrative Clinical Genomics of Advanced Prostate Cancer

Suchergebnisse filtern